TY  - JOUR 
AU  - Valero-Martínez, C.
AU  - Urgelles, J.F.
AU  - Sallés, M.
AU  - Joven-Ibáñez, B.E.
AU  - de Juanes, A.
AU  - Ramírez, J.
AU  - Juanola, X.
AU  - Almodóvar, R.
AU  - Laiz, A.
AU  - Moreno, M.
AU  - Pujol, M.
AU  - Beltrán, E.
AU  - Pinto Tasende, José Antonio
AU  - Crespí, L.
AU  - Sala-Icardo, L.
AU  - Castañeda, S.
AU  - García-Vicuña, R.
PY  - 2023
SN  - 1664-3224
UR  - http://hdl.handle.net/20.500.11940/21373
AB  - Dual targeted therapy (DTT) has emerged as a promising approach in patients with refractory spondyloarthritis (SpA) or psoriatic arthritis (PsA) and extra-musculoskeletal manifestations of both diseases, but its effectiveness/safety ratio still...
LA  - eng
KW  - Humans
KW  - Arthritis, Psoriatic
KW  - Tumor Necrosis Factor Inhibitors
KW  - Retrospective Studies
KW  - Spain
KW  - Spondylarthritis
TI  - Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
DO  - 10.3389/fimmu.2023.1283251
T2  - Frontiers in Immunology
KW  - AS A Coruña
KW  - INIBIC
VL  - 14
ER  -